The global medical rehabilitation robotics market is forecasted to expand at 15.2% CAGR to reach a market valuation of US$ 1.76 Billion by the end of 2033, up from US$ 366.2 Million that was recorded for 2022.
The pediatric rehabilitation robotics is an emerging market. The expansion of rehabilitation services for patients with autism and cerebral palsy to accelerate the market
| Report Attribute | Details |
|---|---|
| Medical Rehabilitation Robotics Market Size (2023) | US$ 428.9 Million |
| Forecasted Market Value (2033) | US$ 1.76 Billion |
| Value CAGR (2023 to 2033) | 15.2% |
| Collective Value Share: Top 5 Countries (2022) | 66.4% |
| Key Market Players | Ekso Bionics Holdings Inc., AlterG, Inc., Bionik Laboratories Corp., Cyberdyne Inc., ReWalk Robotics, Instead Technologies Ltd., Hocoma AG, Fourier Intelligence, Tyromotion Gmbh, Toyota Motor Corporation, BeatBots LLC, Bioxtreme, Rex Bionics Inc., and LEADERS REHAB ROBOT Co. Ltd. |
One of the most desirable and successful applications of the robot in healthcare appears to be rehabilitation. The four steps of a normal rehabilitation session are identifying the patient's condition, defining the rehabilitation goals, organizing and carrying out the treatments, and finally assessing the results.
Robots have the ability to transform and improve this sector by lowering the physical therapist’s burden, allowing less supervision by therapists, and offering more precise tracking of patient development throughout the sessions.
Rehabilitation robotics is designed to support the motion of various sensorimotor functions for mechanical actions including arm, leg, and ankle. These tools aid in accelerating the healing of patients who are dealing with mobility disorders combined with physically weakened bodies.
According to this new medical rehabilitation robotics market survey report by Future Market Insights, the global market has huge growth potential owing to the increased the efficiency of and accessibility to rehabilitation therapy.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The market for medical rehabilitation robotics expanded at a CAGR of 39.5% during the historic period (2017 to 2022) and reached a market value of US$ 366.2 Million in 2022.
The need for robotic rehabilitation in healthcare is being driven by an increase in the population of people with physical disabilities and a decrease in the number of nurses who are available. The World Health Organization estimates that 15 Million people experience a stroke each year. A third of these individuals continue to experience some form of functional disability, making it challenging for them to regain independence in daily life tasks. As such, incidences are increasing; the demand for the medical rehabilitation robotics is rising.
With advances in materials, increased reliability, control software, and the reduction of sensor and actuator size, automated robotics applications are expected to grow. This will enable design and modeling using mechatronics technology to enhance the health of individuals with disabilities.
The global market is predicted to grow stably, to its current size by the end of 2033.
| Market Statistics | Details |
|---|---|
| Jan - Jun (H1), 2021 (A) | 14.85% |
| Jul - Dec (H2), 2021 (A) | 21.06% |
| Jan - Jun (H1),2022 Projected (P) | 14.71% |
| Jan - Jun (H1),2022 Outlook (O) | 15.53% |
| Jul - Dec (H2), 2022 Outlook (O) | 19.69% |
| Jul - Dec (H2), 2022 Projected (P) | 18.35% |
| Jan - Jun (H1), 2023 Projected (P) | 15.49% |
| BPS Change : H1,2022 (O) - H1,2022 (P) | 82↑ |
| BPS Change : H1,2022 (O) - H1,2021 (A) | 68↑ |
| BPS Change: H2, 2022 (O) - H2, 2022 (P) | 134 ↑ |
| BPS Change: H2, 2022 (O) - H2, 2021 (A) | (-)138↓ |
Principal Consultant
Lack of awareness and adoption of rehabilitation facilities
Although the concept of rehabilitation is commonly understood in industrialized economies, it is not widely acknowledged or used in emerging economies. Many patients in developing nations with low and intermediate income levels lack access to rehabilitation services.
Less than 10 skilled practitioners per Million people work in the field of rehabilitation, which is an obstacle to the market's expansion.
Robotics used for rehabilitation services demand significant financial investments, and depending on the type of rehabilitation, their routine maintenance and operations might be rather expensive. Therefore, it is anticipated that the high price of rehabilitation robots will restrain the market's expansion in developing regions.
Patient trust is one of the main barriers to the use of robotics in rehabilitation. For instance, according to a survey conducted by the World Economic Forum, one-third of patients stated they would not trust a robot to regularly clean their teeth. 2/3 of people said they would not trust a robot to perform more complex treatments like root canals.
Robotic rehabilitation for children with physical disabilities could fulfill children’s needs and inspire researchers to develop new devices. Investment in research and development by the leading manufacturers to gain a competitive edge
Most of robotic rehabilitation devices currently available are made for adult patients, whose needs are different from those of pediatric patients. Due to inadequate consideration of pediatric patients' demands, this restricts the gadgets' potential. Research and development of robotic rehabilitation that can meet needs may provide profitable market opportunities.
Whether through collaboration or research contracts with reputable research institutions, leading manufacturers are investing in research initiatives to gain a competitive edge.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Country | The United Stated |
|---|---|
| Market Share (2023) | 44.6% |
| Market Share (2033) | 38.7% |
| BPS Analysis | -590 |
| Country | The United Kingdom |
|---|---|
| Market Share (2023) | 7.1% |
| Market Share (2033) | 5.8% |
| BPS Analysis | -130 |
| Country | Germany |
|---|---|
| Market Share (2023) | 5.7% |
| Market Share (2033) | 4.9% |
| BPS Analysis | -81 |
| Country | Canada |
|---|---|
| Market Share (2023) | 4.8% |
| Market Share (2033) | 3.4% |
| BPS Analysis | -143 |
| Country | China |
|---|---|
| Market Share (2023) | 4.5% |
| Market Share (2033) | 5.6% |
| BPS Analysis | 111 |
The United States is set to hold a share of around 44.6% of the global market in 2023.
People with physical limitations in the area are the drivers driving sales in the medical rehabilitation robots market. For instance, a research in the Journal of Neuro-Engineering and Rehabilitation found that between 249,000 and 363,000 people in the United States have difficulties brought on by spinal cord injuries (SCI) and that 17,730 people suffer a new SCI every year.
Germany is set to hold a share of 5.7% of the global market in 2023.
The region's growing need for medical rehabilitation robots is due to the development of the healthcare sectors. Germany, along with the United Kingdom, Denmark, and Spain, is listed in the TOP-10 of "Countries with the Best Health Care Systems in Europe" according to CEOWorld Magazine.
Japan is set to hold a share of 3.1% of the global market in 2023.
With more than 6,020,000 dementia patients, Japan has already reached the status of a "super-aging society," and with the aid of geriatric rehabilitation procedures, many elderly people with disabilities can live peacefully in their communities. As a result, there is a growing need for medical rehabilitation robotics.
Therapeutics/ assistive products are expected to hold a market share of 74.5% in 2023. The capacity of these devices to help patients move around while gathering sensory data that is processed and customized for patient’s usage to speed up healing is credited with the growth.
The upper extremity segment is predicted to account for 59.0% of the overall market share in the field of extremity during the year 2023. The development of automated robotic assistive devices for patients with impairments and cognitive inequalities is expected to increase as medical prosthesis sales rise.
The limb mobility therapy segment is projected to account for 60.7% of the total market share in the year 2023. The development of structured robotic exoskeleton systems for reducing labor-intensive tasks is expected to boost sales.
The adults are projected to contribute 87.5% revenue share to the global market. This is because older persons with high fall risk were much more likely to report using rehabilitation services than those with low and moderate fall risk. According to a study in NCBI, among older adults, falls are the most common cause of injury, morbidity, and functional impairment. An annual fall affects the health of the public in a substantial way for 30% of persons 65 and over.
The Neurorehabilitation segments predicted to hold more than half of the global value share in 2023. Growing prevalence of neurodegenerative diseases is leading to various behavioral and cognitive function disorders, which in turn boosting the application of rehabilitation robotics for Neurorehabilitation.
Sales in rehabilitation centers accounted for 47.6% of the total market share in 2022 and it is expected to have dominance in the forecast period. Sales in this sector are being driven by growing awareness of rehabilitation treatments that address both the physical and mental components of the disease.
The need for rehabilitation is expected to grow globally due to changes in population health and features, according to the WHO (world health organization). For example, people are living longer, but with more chronic disease and disability.
The market for medical rehabilitation robotics is competitive and has several established companies. Due to the advanced technology acceptance by the patients and the product approvals by the federal agencies of the Department of Health and Human Services, are allowing to compete efficiently. The key market players are promoting the robotic care devices for overseas.
Recent Market Developments
Similarly, recent developments have been tracked by the team at Future Market Insights related to companies in the medical rehabilitation robotics space, which are available in the full report
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2017 to2022 |
| Market Analysis | US$ Million for Value, Units for Volume |
| Key Regions Covered | North America, Latin America, Europe, Asia-Pacific excluding Japan, and the Middle East and Africa |
| Key Countries Covered | The USA, Canada, Brazil, Mexico, Argentina, United Kingdom, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Türkiye, GCC Countries, North Africa, and South Africa |
| Key Market Segments Covered | Product, Extremity, Therapy, Patient, Application, End User and Region |
| Key Companies Profiled |
|
| Pricing | Available upon Request |
The medical rehabilitation robotics market CAGR for 2033 is 15.2%.
The market is estimated to reach US$ 1.76 billion by 2033.
Key medical rehabilitation robotics market players are introducing innovative products.
The market is estimated to secure a valuation of US$ 428.9 million in 2023.
The increasing prevalence of chronic diseases and injuries.
1. Executive Summary | Medical Rehabilitation Robotics Market 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Key Success Factors 4.1. Product Adoption /Usage Analysis 4.2. Technology Assessment 4.3. Promotional Strategies, By Key Players 4.4. Regulatory Landscape 4.5. Reimbursement Outlook 4.6. Supply Chain Analysis 4.7. Porter’s Analysis 4.8. PESTEL Analysis 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Growth Outlook 5.1.2. Global Healthcare Outlook 5.2. Forecast Factors - Relevance & Impact 5.2.1. Rising Prevalence of Chronic Disorders 5.2.2. Availability of Treatment 5.2.3. Cost of Treatment 5.2.4. Increasing Product Approvals 5.2.5. Increasing Cases of Physical Disabilities 5.2.6. Mergers and Acquisitions 5.2.7. Regulatory Policies 5.2.8. Advertisements and Endorsements 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID-19 Crisis Analysis 6.1. COVID-19 and Impact Analysis 6.1.1. By Product 6.1.2. By Extremity 6.1.3. By Therapy 6.1.4. By Patient 6.1.5. By Application 6.1.6. By End User 6.1.7. By Region 6.2. 2022 Market Scenario 7. Global Market Demand (in Volume Units) Analysis 2017 to 2022 and Forecast, 2023 to 2033 7.1. Historical Market Volume (Units) Analysis, 2017 to 2022 7.2. Current and Future Market Volume (units) Projections, 2023 to 2033 7.2.1. Y-o-Y Growth Trend Analysis 8. Global Market - Pricing Analysis 8.1. Regional Pricing Analysis By Product 8.2. Pricing Break-up 8.2.1. Manufacturer Level 8.2.2. Distributor Level 8.3. Global Average Pricing Analysis Benchmark 8.4. Pricing Assumptions 9. Global Market Demand (in Value US$ Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033 9.1. Historical Market Value (US$ Million) Analysis, 2017 to 2022 9.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, by Product, 2017 to 2022 10.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast, by Product, 2023 to 2033 10.3.1. Exoskeleton 10.3.2. Therapeutic/ Assistive 10.4. Market Attractiveness Analysis, by Product 11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Extremity 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Million) Analysis, By Extremity, 2017 to 2022 11.3. Current and Future Market Size (US$ Million) Analysis and Forecast, by Extremity, 2023 to 2033 11.3.1. Upper Extremity 11.3.1.1. Arm 11.3.1.2. Wrist 11.3.1.3. Shoulder 11.3.1.4. Elbow 11.3.2. Lower Extremity 11.4. Market Attractiveness Analysis, by Extremity 12. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Therapy 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Million) Analysis, By Therapy, 2017 to 2022 12.3. Current and Future Market Size (US$ Million) Analysis and Forecast, by Therapy, 2023 to 2033 12.3.1. Limb Mobility 12.3.2. Gait 12.3.3. Sensory 12.4. Market Attractiveness Analysis, by Therapy 13. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Patient 13.1. Introduction / Key Findings 13.2. Historical Market Size (US$ Million) Analysis, By Patient, 2017 to 2022 13.3. Current and Future Market Size (US$ Million) Analysis and Forecast, by Patient, 2023 to 2033 13.3.1. Adults 13.3.2. Pediatric 13.4. Market Attractiveness Analysis, by Patient 14. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application 14.1. Introduction / Key Findings 14.2. Historical Market Size (US$ Million) Analysis, By Application, 2017 to 2022 14.3. Current and Future Market Size (US$ Million) Analysis and Forecast, by Application, 2023 to 2033 14.3.1. Neurorehabilitation 14.3.2. Physical Rehabilitation 14.3.3. Other 14.4. Market Attractiveness Analysis, by Application 15. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User 15.1. Introduction / Key Findings 15.2. Historical Market Size (US$ Million) Analysis, By End User, 2017 to 2022 15.3. Current and Future Market Size (US$ Million) Analysis and Forecast, by End User, 2023 to 2033 15.3.1. Hospitals 15.3.2. Wellness centers 15.3.3. Rehabilitation centers 15.3.4. Others 15.4. Market Attractiveness Analysis, by End User 16. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region 16.1. Introduction 16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, by Region, 2017 to 2022 16.3. Current and Future Market Value (US$ Million) and Volume (Units) Analysis and Forecast, By Region, 2023 to 2033 16.3.1. North America 16.3.2. Latin America 16.3.3. Europe 16.3.4. East Asia 16.3.5. South Asia 16.3.6. Oceania 16.3.7. Middle East and Africa (MEA) 16.4. Market Attractiveness Analysis, by Region 17. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 17.1. Introduction 17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, by Market Taxonomy, 2017 to 2022 17.3. Current and Future Market Value (US$ Million) and Volume (Units) Analysis and Forecast, by Market Taxonomy, 2023 to 2033 17.3.1. By Country 17.3.1.1. The USA 17.3.1.2. Canada 17.3.2. By Product 17.3.3. By Extremity 17.3.4. By Therapy 17.3.5. By Patient 17.3.6. By Application 17.3.7. By End user 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Product 17.4.3. By Extremity 17.4.4. By Therapy 17.4.5. By Patient 17.4.6. By Application 17.4.7. By End user 17.5. Market Trends 17.6. Key Market Participants – Intensity Mapping 17.7. Drivers and Restraints - Impact Analysis 17.8. Country Level Analysis & Forecast 17.8.1. USA Market Analysis 17.8.1.1. Introduction 17.8.1.2. Market Analysis and Forecast, by Market Taxonomy 17.8.1.2.1. By Product 17.8.1.2.2. By Extremity 17.8.1.2.3. By Therapy 17.8.1.2.4. By Patient 17.8.1.2.5. By Application 17.8.1.2.6. By End User 17.8.2. Canada Market Analysis 17.8.2.1. Introduction 17.8.2.2. Market Analysis and Forecast, by Market Taxonomy 17.8.2.2.1. By Product 17.8.2.2.2. By Extremity 17.8.2.2.3. By Therapy 17.8.2.2.4. By Patient 17.8.2.2.5. By Application 17.8.2.2.6. By End User 18. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 18.1. Introduction 18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, by Market Taxonomy, 2017 to 2022 18.3. Current and Future Market Value (US$ Million) and Volume (Units) Analysis and Forecast, by Market Taxonomy, 2023 to 2033 18.3.1. By Country 18.3.1.1. Mexico 18.3.1.2. Brazil 18.3.1.3. Argentina 18.3.1.4. Rest of Latin America 18.3.2. By Product 18.3.3. By Extremity 18.3.4. By Therapy 18.3.5. By Patient 18.3.6. By Application 18.3.7. By End User 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Product 18.4.3. By Extremity 18.4.4. By Therapy 18.4.5. By Patient 18.4.6. By Application 18.4.7. By End User 18.5. Market Trends 18.6. Key Market Participants – Intensity Mapping 18.7. Drivers and Restraints - Impact Analysis 18.8. Country Level Analysis & Forecast 18.8.1. Mexico Market Analysis 18.8.1.1. Introduction 18.8.1.2. Market Analysis and Forecast, by Market Taxonomy 18.8.1.2.1. By Product 18.8.1.2.2. By Extremity 18.8.1.2.3. By Therapy 18.8.1.2.4. By Patient 18.8.1.2.5. By Application 18.8.1.2.6. By End User 18.8.2. Brazil Market Analysis 18.8.2.1. Introduction 18.8.2.2. Market Analysis and Forecast, by Market Taxonomy 18.8.2.2.1. By Product 18.8.2.2.2. By Extremity 18.8.2.2.3. By Therapy 18.8.2.2.4. By Patient 18.8.2.2.5. By Application 18.8.2.2.6. By End User 18.8.3. Argentina Market Analysis 18.8.3.1. Introduction 18.8.3.2. Market Analysis and Forecast, by Market Taxonomy 18.8.3.2.1. By Product 18.8.3.2.2. By Extremity 18.8.3.2.3. By Therapy 18.8.3.2.4. By Patient 18.8.3.2.5. By Application 18.8.3.2.6. By End User 19. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033 19.1. Introduction 19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, by Market Taxonomy, 2017 to 2022 19.3. Current and Future Market Value (US$ Million) and Volume (Units) Analysis and Forecast, by Market Taxonomy, 2023 to 2033 19.3.1. By Country 19.3.1.1. Germany 19.3.1.2. Italy 19.3.1.3. France 19.3.1.4. United Kingdom 19.3.1.5. Spain 19.3.1.6. BENELUX 19.3.1.7. Russia 19.3.1.8. Rest of Europe 19.3.2. By Product 19.3.3. By Extremity 19.3.4. By Therapy 19.3.5. By Patient 19.3.6. By Application 19.3.7. By End User 19.4. Market Attractiveness Analysis 19.4.1. By Country 19.4.2. By Product 19.4.3. By Extremity 19.4.4. By Therapy 19.4.5. By Patient 19.4.6. By Application 19.4.7. By End User 19.5. Market Trends 19.6. Key Market Participants – Intensity Mapping 19.7. Drivers and Restraints - Impact Analysis 19.8. Country Level Analysis & Forecast 19.8.1. Germany Market Analysis 19.8.1.1. Introduction 19.8.1.2. Market Analysis and Forecast, by Market Taxonomy 19.8.1.2.1. By Product 19.8.1.2.2. By Extremity 19.8.1.2.3. By Therapy 19.8.1.2.4. By Patient 19.8.1.2.5. By Application 19.8.1.2.6. By End User 19.8.2. Italy Market Analysis 19.8.2.1. Introduction 19.8.2.2. Market Analysis and Forecast, by Market Taxonomy 19.8.2.2.1. By Product 19.8.2.2.2. By Extremity 19.8.2.2.3. By Therapy 19.8.2.2.4. By Patient 19.8.2.2.5. By Application 19.8.2.2.6. By End User 19.8.3. France Market Analysis 19.8.3.1. Introduction 19.8.3.2. Market Analysis and Forecast, by Market Taxonomy 19.8.3.2.1. By Product 19.8.3.2.2. By Extremity 19.8.3.2.3. By Therapy 19.8.3.2.4. By Patient 19.8.3.2.5. By Application 19.8.3.2.6. By End User 19.8.4. United Kingdom Market Analysis 19.8.4.1. Introduction 19.8.4.2. Market Analysis and Forecast, by Market Taxonomy 19.8.4.2.1. By Product 19.8.4.2.2. By Extremity 19.8.4.2.3. By Therapy 19.8.4.2.4. By Patient 19.8.4.2.5. By Application 19.8.4.2.6. By End User 19.8.5. Spain Market Analysis 19.8.5.1. Introduction 19.8.5.2. Market Analysis and Forecast, by Market Taxonomy 19.8.5.2.1. By Product 19.8.5.2.2. By Extremity 19.8.5.2.3. By Therapy 19.8.5.2.4. By Patient 19.8.5.2.5. By Application 19.8.5.2.6. By End User 19.8.6. BENELUX Market Analysis 19.8.6.1. Introduction 19.8.6.2. Market Analysis and Forecast, by Market Taxonomy 19.8.6.2.1. By Product 19.8.6.2.2. By Extremity 19.8.6.2.3. By Therapy 19.8.6.2.4. By Patient 19.8.6.2.5. By Application 19.8.6.2.6. By End User 19.8.7. Russia Market Analysis 19.8.7.1. Introduction 19.8.7.2. Market Analysis and Forecast, by Market Taxonomy 19.8.7.2.1. By Product 19.8.7.2.2. By Extremity 19.8.7.2.3. By Therapy 19.8.7.2.4. By Patient 19.8.7.2.5. By Application 19.8.7.2.6. By End User 20. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 20.1. Introduction 20.2. Historical Market Patient (US$ Million) and Volume (Units) Analysis, by Market Taxonomy, 2017 to 2022 20.3. Current and Future Market Value (US$ Million) and Volume (Units) Analysis and Forecast, by Market Taxonomy, 2023 to 2033 20.3.1. By Country 20.3.1.1. China 20.3.1.2. Japan 20.3.1.3. South Korea 20.3.2. By Product 20.3.3. By Extremity 20.3.4. By Therapy 20.3.5. By Patient 20.3.6. By Application 20.3.7. By End User 20.4. Market Attractiveness Analysis 20.4.1. By Product 20.4.2. By Extremity 20.4.3. By Therapy 20.4.4. By Patient 20.4.5. By Application 20.4.6. By End User 20.5. Market Trends 20.6. Key Market Participants – Intensity Mapping 20.7. Drivers and Restraints - Impact Analysis 20.8. Country Level Analysis & Forecast 20.8.1. China Market Analysis 20.8.1.1. Introduction 20.8.1.2. Market Analysis and Forecast, by Market Taxonomy 20.8.1.2.1. By Product 20.8.1.2.2. By Extremity 20.8.1.2.3. By Therapy 20.8.1.2.4. By Patient 20.8.1.2.5. By Application 20.8.1.2.6. By End User 20.8.2. Japan Market Analysis 20.8.2.1. Introduction 20.8.2.2. Market Analysis and Forecast, by Market Taxonomy 20.8.2.2.1. By Product 20.8.2.2.2. By Extremity 20.8.2.2.3. By Therapy 20.8.2.2.4. By Patient 20.8.2.2.5. By Application 20.8.2.2.6. By End User 20.8.3. South Korea Market Analysis 20.8.3.1. Introduction 20.8.3.2. Market Analysis and Forecast, by Market Taxonomy 20.8.3.2.1. By Product 20.8.3.2.2. By Extremity 20.8.3.2.3. By Therapy 20.8.3.2.4. By Patient 20.8.3.2.5. By Application 20.8.3.2.6. By End User 21. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 21.1. Introduction 21.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, by Market Taxonomy, 2017 to 2022 21.3. Current and Future Market Value (US$ Million) and Volume (Units) Analysis and Forecast, by Market Taxonomy, 2023 to 2033 21.3.1. By Country 21.3.1.1. India 21.3.1.2. Indonesia 21.3.1.3. Malaysia 21.3.1.4. Thailand 21.3.1.5. Rest of South Asia 21.3.2. By Product 21.3.3. By Extremity 21.3.4. By Therapy 21.3.5. By Patient 21.3.6. By Application 21.3.7. By End User 21.4. Market Attractiveness Analysis 21.4.1. By Country 21.4.2. By Product 21.4.3. By Extremity 21.4.4. By Therapy 21.4.5. By Patient 21.4.6. By Application 21.4.7. By End User 21.5. Market Trends 21.6. Key Market Participants – Intensity Mapping 21.7. Drivers and Restraints - Impact Analysis 21.8. Country Level Analysis & Forecast 21.8.1. India Market Analysis 21.8.1.1. Introduction 21.8.1.2. Market Analysis and Forecast, by Market Taxonomy 21.8.1.2.1. By Product 21.8.1.2.2. By Extremity 21.8.1.2.3. By Therapy 21.8.1.2.4. By Patient 21.8.1.2.5. By Application 21.8.1.2.6. By End User 21.8.2. Indonesia Market Analysis 21.8.2.1. Introduction 21.8.2.2. Market Analysis and Forecast, by Market Taxonomy 21.8.2.2.1. By Product 21.8.2.2.2. By Extremity 21.8.2.2.3. By Therapy 21.8.2.2.4. By Patient 21.8.2.2.5. By Application 21.8.2.2.6. By End User 21.8.3. Malaysia Market Analysis 21.8.3.1. Introduction 21.8.3.2. Market Analysis and Forecast, by Market Taxonomy 21.8.3.2.1. By Product 21.8.3.2.2. By Extremity 21.8.3.2.3. By Therapy 21.8.3.2.4. By Patient 21.8.3.2.5. By Application 21.8.3.2.6. By End User 21.8.4. Thailand Market Analysis 21.8.4.1. Introduction 21.8.4.2. Market Analysis and Forecast, by Market Taxonomy 21.8.4.2.1. By Product 21.8.4.2.2. By Extremity 21.8.4.2.3. By Therapy 21.8.4.2.4. By Patient 21.8.4.2.5. By Application 21.8.4.2.6. By End User 22. Oceania Market 2012 to 2022 and Forecast 2022-2033 22.1. Introduction 22.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, by Market Taxonomy, 2017 to 2022 22.3. Current and Future Market Value (US$ Million) and Volume (Units) Analysis and Forecast, by Market Taxonomy, 2023 to 2033 22.3.1. By Country 22.3.1.1. Australia 22.3.1.2. New Zealand 22.3.2. By Product 22.3.3. By Extremity 22.3.4. By Therapy 22.3.5. By Patient 22.3.6. By Application 22.3.7. By End User 22.4. Market Attractiveness Analysis 22.4.1. By Country 22.4.2. By Product 22.4.3. By Extremity 22.4.4. By Therapy 22.4.5. By Patient 22.4.6. By Application 22.4.7. By End User 22.5. Market Trends 22.6. Key Market Participants – Intensity Mapping 22.7. Drivers and Restraints - Impact Analysis 22.8. Country Level Analysis & Forecast 22.8.1. Australia Market Analysis 22.8.1.1. Introduction 22.8.1.2. Market Analysis and Forecast, by Market Taxonomy 22.8.1.2.1. By Product 22.8.1.2.2. By Extremity 22.8.1.2.3. By Therapy 22.8.1.2.4. By Patient 22.8.1.2.5. By Application 22.8.1.2.6. By End User 22.8.2. New Zealand Market Analysis 22.8.2.1. Introduction 22.8.2.2. Market Analysis and Forecast, by Market Taxonomy 22.8.2.2.1. By Product 22.8.2.2.2. By Extremity 22.8.2.2.3. By Therapy 22.8.2.2.4. By Patient 22.8.2.2.5. By Application 22.8.2.2.6. By End User 23. Middle East and Africa (MEA) Market Analysis 2017 to 2022 and Forecast 2023 to 2033 23.1. Introduction 23.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, by Market Taxonomy, 2017 to 2022 23.3. Current and Future Market Value (US$ Million) and Volume (Units) Analysis and Forecast, by Market Taxonomy, 2023 to 2033 23.3.1. By Country 23.3.1.1. GCC Countries 23.3.1.2. Türkiye 23.3.1.3. South Africa 23.3.1.4. North Africa 23.3.1.5. Rest of Middle East and Africa 23.3.2. By Product 23.3.3. By Extremity 23.3.4. By Therapy 23.3.5. By Patient 23.3.6. By Application 23.3.7. By End User 23.4. Market Attractiveness Analysis 23.4.1. By Product 23.4.2. By Extremity 23.4.3. By Therapy 23.4.4. By Patient 23.4.5. By Application 23.4.6. By End User 23.5. Market Trends 23.6. Key Market Participants – Intensity Mapping 23.7. Drivers and Restraints - Impact Analysis 23.8. Country Level Analysis & Forecast 23.8.1. GCC Countries Market Analysis 23.8.1.1. Introduction 23.8.1.2. Market Analysis and Forecast, by Market Taxonomy 23.8.1.2.1. By Product 23.8.1.2.2. By Extremity 23.8.1.2.3. By Therapy 23.8.1.2.4. By Patient 23.8.1.2.5. By Application 23.8.1.2.6. By End User 23.8.2. Türkiye Market Analysis 23.8.2.1. Introduction 23.8.2.2. Market Analysis and Forecast, by Market Taxonomy 23.8.2.2.1. By Product 23.8.2.2.2. By Extremity 23.8.2.2.3. By Therapy 23.8.2.2.4. By Patient 23.8.2.2.5. By Application 23.8.2.2.6. By End User 23.8.3. South Africa Market Analysis 23.8.3.1. Introduction 23.8.3.2. Market Analysis and Forecast, by Market Taxonomy 23.8.3.2.1. By Product 23.8.3.2.2. By Extremity 23.8.3.2.3. By Therapy 23.8.3.2.4. By Patient 23.8.3.2.5. By Application 23.8.3.2.6. By End User 23.8.4. North Africa Market Analysis 23.8.4.1. Introduction 23.8.4.2. Market Analysis and Forecast, by Market Taxonomy 23.8.4.2.1. By Product 23.8.4.2.2. By Extremity 23.8.4.2.3. By Therapy 23.8.4.2.4. By Patient 23.8.4.2.5. By Application 23.8.4.2.6. By End User 24. Market Structure Analysis 24.1. Market Analysis, by Tier of Companies 24.2. Market Share Analysis of Top Players 24.3. Market Presence Analysis 25. Competition Analysis 25.1. Competition Dashboard 25.2. Competition Benchmarking 25.3. Competition Deep Dive 25.3.1. Ekso Bionics Holdings Inc. 25.3.1.1. Overview 25.3.1.2. Product Portfolio 25.3.1.3. Sales Footprint 25.3.1.4. Key Financials 25.3.1.5. SWOT Analysis 25.3.1.6. Strategy Overview 25.3.1.6.1. Marketing Strategy 25.3.1.6.2. Product Strategy 25.3.1.6.3. Channel Strategy 25.3.2. AlterG, Inc. 25.3.2.1. Overview 25.3.2.2. Product Portfolio 25.3.2.3. Sales Footprint 25.3.2.4. Key Financials 25.3.2.5. SWOT Analysis 25.3.2.6. Strategy Overview 25.3.2.6.1. Marketing Strategy 25.3.2.6.2. Product Strategy 25.3.2.6.3. Channel Strategy 25.3.3. Bionik Laboratories Corp. 25.3.3.1. Overview 25.3.3.2. Product Portfolio 25.3.3.3. Sales Footprint 25.3.3.4. Key Financials 25.3.3.5. SWOT Analysis 25.3.3.6. Strategy Overview 25.3.3.6.1. Marketing Strategy 25.3.3.6.2. Product Strategy 25.3.3.6.3. Channel Strategy 25.3.4. Cyberdyne Inc. 25.3.4.1. Overview 25.3.4.2. Product Portfolio 25.3.4.3. Sales Footprint 25.3.4.4. Key Financials 25.3.4.5. SWOT Analysis 25.3.4.6. Strategy Overview 25.3.4.6.1. Marketing Strategy 25.3.4.6.2. Product Strategy 25.3.4.6.3. Channel Strategy 25.3.5. ReWalk Robotics 25.3.5.1. Overview 25.3.5.2. Product Portfolio 25.3.5.3. Sales Footprint 25.3.5.4. Key Financials 25.3.5.5. SWOT Analysis 25.3.5.6. Strategy Overview 25.3.5.6.1. Marketing Strategy 25.3.5.6.2. Product Strategy 25.3.5.6.3. Channel Strategy 25.3.6. Instead Technologies Ltd. 25.3.6.1. Overview 25.3.6.2. Product Portfolio 25.3.6.3. Sales Footprint 25.3.6.4. Key Financials 25.3.6.5. SWOT Analysis 25.3.6.6. Strategy Overview 25.3.6.6.1. Marketing Strategy 25.3.6.6.2. Product Strategy 25.3.6.6.3. Channel Strategy 25.3.7. Bioxtreme 25.3.7.1. Overview 25.3.7.2. Product Portfolio 25.3.7.3. Sales Footprint 25.3.7.4. Key Financials 25.3.7.5. SWOT Analysis 25.3.7.6. Strategy Overview 25.3.7.6.1. Marketing Strategy 25.3.7.6.2. Product Strategy 25.3.7.6.3. Channel Strategy 25.3.8. Rex Bionics Ltd 25.3.8.1. Overview 25.3.8.2. Product Portfolio 25.3.8.3. Sales Footprint 25.3.8.4. Key Financials 25.3.8.5. SWOT Analysis 25.3.8.6. Strategy Overview 25.3.8.6.1. Marketing Strategy 25.3.8.6.2. Product Strategy 25.3.8.6.3. Channel Strategy 25.3.9. Hocoma AG 25.3.9.1. Overview 25.3.9.2. Product Portfolio 25.3.9.3. Sales Footprint 25.3.9.4. Key Financials 25.3.9.5. SWOT Analysis 25.3.9.6. Strategy Overview 25.3.9.6.1. Marketing Strategy 25.3.9.6.2. Product Strategy 25.3.9.6.3. Channel Strategy 25.3.10. Fourier Intelligence 25.3.10.1. Overview 25.3.10.2. Product Portfolio 25.3.10.3. Sales Footprint 25.3.10.4. Key Financials 25.3.10.5. SWOT Analysis 25.3.10.6. Strategy Overview 25.3.10.6.1. Marketing Strategy 25.3.10.6.2. Product Strategy 25.3.10.6.3. Channel Strategy 25.3.11. Tyromotion Gmbh 25.3.11.1. Overview 25.3.11.2. Product Portfolio 25.3.11.3. Sales Footprint 25.3.11.4. Key Financials 25.3.11.5. SWOT Analysis 25.3.11.6. Strategy Overview 25.3.11.6.1. Marketing Strategy 25.3.11.6.2. Product Strategy 25.3.11.6.3. Channel Strategy 25.3.12. Toyota Motor Corporation 25.3.12.1. Overview 25.3.12.2. Product Portfolio 25.3.12.3. Sales Footprint 25.3.12.4. Key Financials 25.3.12.5. SWOT Analysis 25.3.12.6. Strategy Overview 25.3.12.6.1. Marketing Strategy 25.3.12.6.2. Product Strategy 25.3.12.6.3. Channel Strategy 25.3.13. BeatBots LLC 25.3.13.1. Overview 25.3.13.2. Product Portfolio 25.3.13.3. Sales Footprint 25.3.13.4. Key Financials 25.3.13.5. SWOT Analysis 25.3.13.6. Strategy Overview 25.3.13.6.1. Marketing Strategy 25.3.13.6.2. Product Strategy 25.3.13.6.3. Channel Strategy 25.3.14. LEADERS REHAB ROBOT Co. Ltd. 25.3.14.1. Overview 25.3.14.2. Product Portfolio 25.3.14.3. Sales Footprint 25.3.14.4. Key Financials 25.3.14.5. SWOT Analysis 25.3.14.6. Strategy Overview 25.3.14.6.1. Marketing Strategy 25.3.14.6.2. Product Strategy 25.3.14.6.3. Channel Strategy 26. Assumptions and Acronyms Used 27. Research Methodology
Explore Healthcare Insights
View Reports
Medical Rehabilitation Robotics Market
